These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions. Pulanić R, Dubravcić D, Ostojić-Pulanić B, Vrhovac B. Acta Med Croatica; 1998 Dec; 52(2):91-8. PubMed ID: 9682495 [Abstract] [Full Text] [Related]
3. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Laine L. Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071 [Abstract] [Full Text] [Related]
4. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors]. Karateev AE, Nasonova VA. Ter Arkh; 2008 Dec; 80(5):62-6. PubMed ID: 18590118 [Abstract] [Full Text] [Related]
6. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs]. Dobrilla G, Benvenuti S, de Guelmi A. Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954 [Abstract] [Full Text] [Related]
7. [Digestive complications of non-steroidal anti-inflammatory drugs]. Colin R. Schweiz Med Wochenschr; 1991 May 18; 121(20):716-21. PubMed ID: 2057738 [Abstract] [Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug gastropathy. Laine L. Gastrointest Endosc Clin N Am; 1996 Jul 18; 6(3):489-504. PubMed ID: 8803564 [Abstract] [Full Text] [Related]
9. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases]. Karateev AE, Nasonova VA, Murav'ev IuV. Ter Arkh; 1999 Jul 18; 71(2):26-30. PubMed ID: 10222549 [Abstract] [Full Text] [Related]
10. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. Miller DR. Clin Pharm; 1992 Aug 18; 11(8):690-704. PubMed ID: 1511542 [Abstract] [Full Text] [Related]
16. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage. Bellary SV, Isaacs PE, Lee FI. Am J Gastroenterol; 1991 Aug 18; 86(8):961-4. PubMed ID: 1858761 [Abstract] [Full Text] [Related]
17. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia]. Karataev AE, Konovalova NN, Litovshenko AA, Lomareva NI, Nemtsov BF, Raskina TA, Peshekhonova LK, Nasonov EL. Klin Med (Mosk); 2005 Aug 18; 83(5):33-8. PubMed ID: 15984580 [Abstract] [Full Text] [Related]
18. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. Clin Ther; 2006 Mar 18; 28(3):340-51. PubMed ID: 16750449 [Abstract] [Full Text] [Related]
19. [Present position in the prevention and therapy of NSAID-induced ulcers]. Lehmann FS, Beglinger C. Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910 [Abstract] [Full Text] [Related]
20. The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials. Boers M, Tangelder MJ, van Ingen H, Fort JG, Goldstein JL. Ann Rheum Dis; 2007 Mar 27; 66(3):417-8. PubMed ID: 16887862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]